OPERA II study: MAdCAM-1 antibody SHP647 TrialOPERA II ConferenceECCO 2019 TypePeer-reviewed article 9 May 2019 18:31
SHP647 is efficacious and well-tolerated in CD TrialOPERA I, OPERA II, TOSCA ConferenceECCO 2018 TypePeer-reviewed article 28 May 2018 18:53